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Abstract: Multiple genetic variants are known to influence athletic performance. These include
polymorphisms of the muscle-specific creatine kinase (CKM) gene, which have been associated with
endurance and/or power phenotypes. However, independent replication is required to support those
findings. The aim of the present study was to determine whether the CKM (rs8111989, c.*800A>G)
polymorphism is associated with power athlete status in professional Russian and Lithuanian
competitors. Genomic DNA was collected from 693 national and international standard athletes from
Russia (n = 458) and Lithuania (n = 235), and 500 healthy non-athlete subjects from Russia (n = 291)
and Lithuania (n = 209). Genotyping for the CKM rs8111989 (A/G) polymorphism was performed
using PCR or micro-array analysis. Genotype and allele frequencies were compared between all
athletes and non-athletes, and between non-athletes and athletes, segregated according to population
and sporting discipline (from anaerobic-type events). No statistically significant differences in
genotype or allele frequencies were observed between non-athletes and power athletes (strength-,
sprint- and speed/strength-oriented) athletes. The present study reports the non-association of
the CKM rs8111989 with elite status in athletes from sports in which anaerobic energy pathways
determine success.
Keywords: anaerobic performance; creatine kinase; genetic variant; genotype
1. Introduction
Human physical performance is genetically influenced, particularly in sprint/power
sports, with traits relating to muscular strength and power tending to have greater her-
itable components than endurance phenotypes [1]. Although the genetic contribution
to athletic performance is undoubted, a conclusive list of the genetic variants involved,
and the mechanisms underpinning their effect, remain unknown. Among several genes
previously associated with athletic performance, the role of the muscle-specific creatine
kinase (CKM) in cellular energy homeostasis has led to the emergence of the CKM gene as
an important candidate [2,3].
Muscular energy provision is maintained by adenosine triphosphate (ATP) break-
down and the concomitant release of free energy. To sustain contractile activity, the rate of
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ATP regeneration must be complementary to ATP demand and is facilitated by the phos-
phagen, glycolytic, and mitochondrial respiration energy systems. Each system has specific
substrates and byproducts, in addition to differences in maximal rates and capacities for
ATP regeneration [4]. During short-duration, maximal-effort activities such as sprinting,
strength training, and high-power sports, the circulatory system cannot fully supply the
exercising musculature with the oxygen required for adequate mitochondrial respiration.
Consequently, the phosphagen system utilizes intramuscular stores of high-energy phos-
phates, with creatine phosphate (CrP) being the primary component of this system. The
resynthesis of ATP from adenosine diphosphate (ADP) is catalyzed by the enzyme creatine
kinase (CrP + ADP + H+ 
 ATP + Cr), meaning the efficiency of ATP generation is affected
by the activity of creatine kinase [4,5].
Creatine kinase (CK) can be comprised of the M (muscle) and B (brain) subunits,
assembled into the homodimeric CK-M and CK-B enzymes or the CK-MB heterodimer.
Each is expressed in a tissue-specific manner, with CK-M being the most abundant in
skeletal muscle and CK-MB activity being the greatest in cardiac muscle. The CK-B ho-
modimer is primarily expressed in nervous tissue, with small concentrations in skeletal
muscle, whereas the additional CK isoforms Scmit-CK and Umit-CK are localized to the
mitochondria. The abundance of CK-M in skeletal muscle means it is the most important
CK isoform for energy regulation during exercise, with recent evidence suggesting that
the CK-PCr system activity is genetically influenced [5]. The CK-M-encoding CKM gene
is mapped to chromosome 19q13.2, and various studies have addressed the gene’s role
in skeletal muscle energy metabolism. A seminal study by van Deursen and colleagues
showed that CK-M-knockout mice were unable to sustain maximal isometric contractions
but had greater fatigue resistance and could perform a higher number of contractions to
exhaustion [6]. Subsequent studies in rat models demonstrated that both the duration and
intensity of endurance training have a negative linear relationship with CKM expression [7].
Additional animal studies focused on the consequences of CKM knockout in different
muscle fiber types, reporting that CKM activity is inversely correlated with aerobic capacity
and endurance performance. Accordingly, targeted deletion using animal models has per-
mitted the greater understanding of the role of CK-M in exercise performance, suggesting
that higher expression may be detrimental to aerobic capacity but advantageous during
anaerobic activity.
Human studies have focused on sequence variations in coding and noncoding regions
of the CKM gene. More than 260 CKM single-nucleotide polymorphisms (SNPs) have been
identified [8]. The most studied CKM SNP is rs8111989, where adenosine (A) is substituted
with guanine (G) at nucleotide position 800 (c.*800A>G) [8]. Despite being located in the 3′
untranslated region and without altering the amino acid composition of CK-M, this variant
purportedly affects CKM gene expression and CK-M activity [9]. Since the association of
the rs8111989 A allele with endurance phenotypes before and after aerobic training was
reported by Rivera and colleagues [10], several studies of the rs8111989 SNP have been
published [3,5,11–15]. However, there is still a lack of consensus regarding the influence
of the rs8111989 A and G alleles on athletic ability, meaning that replication studies using
independent populations are needed to confirm or reject the association of rs8111989 with
performance phenotypes. Therefore, the aim of this study was to determine whether the
CKM (A/G) rs8111989 polymorphism is associated with elite power status in a cohort of
Lithuanian and Russian athletes. We hypothesized that rs8111989 genotype distribution
would differ between elite power athletes and non-athletes, and that the frequency of the
G allele and GG genotype would be higher in athletes competing in sports that are reliant
on anaerobic energy production.
2. Materials and Methods
2.1. Subjects and Ethical Approval
All procedures in this study conformed with ethical standards concerning the scientific
research of sport and exercise, and were approved by the local Ethics Committees (Federal
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Research and Clinical Center of Physical-Chemical Medicine and the Lithuanian Bioethics
Committee). Written informed consent was obtained from all participants and the study
was conducted in compliance with the Declaration of Helsinki.
This case-control study included 458 Russian (RU) and 235 Lithuanian (LT) profes-
sional athletes (431 males and 262 females, aged 25.0 ± 6.5 years). All athletes were ranked
in the top 10 nationally for their respective sporting disciplines and were prospectively
stratified into three groups according to the duration and distance of their event, span-
ning a spectrum from sprint-oriented (athletes from strength/power sports with some
aerobic component) to strength-oriented (athletes from strength/power sports with a pre-
dominantly anaerobic component). The sprint-oriented group (RU: n = 171; LT: n = 83)
included athletes competing in short-distance races, including 100–400 m track-and-field
sprinters, sprint cycling, rowing/canoe, and canoe-kayak sprints, 50–ß100 m swim and
500–1000 m track races. The strength-oriented group (RU: n = 105; LT: n = 29) included
weightlifters and powerlifters. The speed-/strength-oriented group (RU: n = 182; LT:
n = 123) included athletes from track-and-field (throwing (push-throw), jump events (high
jump, long jump, triple jump, and pole vault)), figure skating, alpine skiing, pentathlon,
decathlon, heptathlon, rock climbing, rhythmic gymnastics, and wrestling. The inclusion
criteria stipulated that athletes must have no history of positive tests for performance-
enhancing substances under standard anti-doping controls. Non-athlete participants were
500 healthy, unrelated citizens (347 males and 153 females, aged 29.0 ± 8.5 years) from Rus-
sia (n = 291) and Lithuania (n = 209), all of whom had no competitive sporting experience.
All participants were Caucasians.
2.2. Genotyping
For all Lithuanian samples, genomic DNA was extracted from peripheral blood leuko-
cytes of the Lithuanian participants using a standard phenol-chloroform extraction method.
Genotyping for CKM rs8111989 was performed in duplicate using an allelic discrimination
assay on a 7900HT Fast real-time polymerase chain reaction (PCR) instrument (Applied
Biosystems™, Life Technologies, Waltham, MA, USA) with TaqMan probes (TaqMan®
Pre-Designed SNP Genotyping Assay ID:C_3145002_10; Applied Biosystems™, Life Tech-
nologies, Waltham, MA, USA). Genotypes were assigned using software (SDS Software
v2.3, Applied BiosystemsTM). In order to ensure proper internal control, positive and
negative controls from different DNA aliquots were used for each genotype analysis.
For all Russian samples, molecular genetic analysis was performed with DNA samples
obtained from leukocytes (venous blood). Four milliliters of venous blood was collected in
tubes containing EDTA (Vacuette EDTA tubes; Greiner Bio-One, Kremsmünster, Austria).
Blood samples were transported to the laboratory at 4 ◦C, and DNA was extracted on
the same day. DNA extraction and purification were performed using a commercial kit
(Techno-Sorb, Moscow, Russia) according to the manufacturer’s instructions (Technoclon,
Moscow, Russia), which included chemical lysis, selective DNA binding on silica spin
columns, and ethanol washing. The extracted DNA quality was assessed by means of
agarose gel electrophoresis. The genotyping process was performed using HumanOmni1-
Quad BeadChips or HumanOmniExpress BeadChips (Illumina, San Diego, CA, USA) to
genotype > 900,000 SNPs, including CKM rs8111989. The assay required 200 ng of DNA
sample as input with a concentration of at least 50 ng/µL. Exact concentrations of DNA
in each sample were measured using a Qubit Fluorometer (Invitrogen, Waltham, MA,
USA). All further procedures were performed according to the instructions of the Infinium
High-Density Assay. Ten percent of samples were genotyped twice with a 100% success
rate of reproducibility.
2.3. Statistical Analyses
Genotype frequencies of athletes and non-athletes were tested for compatibility with
the Hardy–Weinberg equilibrium (HWE). Differences in genotype and allele frequency
were compared using the Chi-squared goodness-of-fit test. The homogeneity hypothesis for
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genotype and allele frequency differences between groups were assessed by Chi-squared
or Fisher’s exact tests where appropriate. Odds ratios (OR) with 95% confidence intervals
(CIs) were calculated in cases where there was a significant difference in the genotype
distribution between groups. The level of significance was set at p < 0.05. All analysis was
performed using the SPSS statistical software package (IBM SPSS v.21).
3. Results
The distributions of CKM rs8111989 genotypes in athletes versus controls are presented
in Table 1. Genotype distributions were in the Hardy–Weinberg Equilibrium for athletes
and non-athletes (in all groups tested separately, p > 0.05).
Table 1. Genotype and allele frequencies of the CKM rs8111989 SNP in athletes and non-athletes from Russia and Lithuania.
Groups N
Allele Frequency (%) p-Value vs.
Non-Athletes
CKM Genotype Frequency (%) p-Value vs.
Non-AthletesA G AA AG GG
All strength-oriented 134 67.2 32.8 0.496 65 (48.5) 50 (37.3) 19 (14.2) 0.246
All sprint-oriented 254 64.4 35.6 0.914 107 (42.1) 113 (44.5) 34 (13.4) 0.980
All speed/strength 305 65.2 34.8 0.720 136 (44.6) 126 (41.3) 43 (14.1) 0.556
Russian power athletes 458 65.6 34.4 0.988 204 (44.5) 193 (42.2) 61 (13.3) 0.915
Lithuanian power athletes 235 64.7 35.3 0.858 104 (44.3) 96 (40.8) 35 (14.9) 0.534
All power athletes 693 65.3 34.7 0.98 308 (44.4) 289 (41.7) 96 (13.9) 0.475
Russian non-athletes 291 66.7 33.3 - 133 (45.7) 122 (41.9) 36 (12.4) -
Lithuanian non-athletes 209 60.3 39.7 - 74 (35.4) 104 (49.8) 31 (14.8) -
All non-athletes 500 64.0 36.0 - 207 (41.4) 226 (45.2) 67 (13.4) -
No statistically significant differences in CKM genotype or allele distribution were
observed compared to non-athletes when all athletes were combined, nor when athletes
were segregated by country (Table 1). In addition, CKM genotype and allele frequencies
did not differ between male and female athletes and non-athletes for each nationality.
4. Discussion
Sports events that involve short intense efforts are often categorized as anaerobic
athletic activities. Each of these events may emphasize different anaerobic phenotypes,
for example, sprinting relies mostly on speed, weightlifting or powerlifting rely mainly
on muscle strength, and throwing and jump events rely on the combination of speed
and strength [15–17]. Therefore, the aim of this study was to investigate differences in
the CKM rs8111989 genotype between three groups of elite athletes from anaerobic-type
events: sprint-oriented, strength-oriented, and speed/strength-oriented athletes. We chose
to study the rs8111989 genetic variant because the CKM gene has emerged as a potential
candidate to affect the development of anaerobic phenotypes. We hypothesized that a
genetic predisposition for high CK-M protein activity in skeletal muscle may be favorable
to power/strength athletes, and specifically that the GG genotype would be more common
in strength and power competitors, due to previous associations with increased CK-M
activity. This theory is supported by rodent models documenting the inverse relationship
of CKM activity with endurance capacity [7], suggesting that high CKM activity may impair
aerobic performance yet favor anaerobic activity. This study led us to conclude that the
genotype and/or allele frequencies of the CKM rs8111989 polymorphism do not seem
to influence performance in either the total strength/power group or in sports groups
from two discrete populations. Nevertheless, this study emphasizes the importance of
considering well-defined groups of athletes with a clear phenotype in genetic association
studies applied to elite sport performance.
Muscular strength is a determinant of general athletic ability in many sports, particu-
larly in short-distance sprinting, and strength and power events, in which the physiological
characteristics favorable to national and international standard competition are well docu-
mented [12,15,16,18]. In contrast with endurance competitors, strength and power athletes
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typically exhibit greater percentages of fast-twitch muscle fibers than slow-twitch fibers [17],
and those fast-twitch fibers are suited to the shorter, more powerful muscle contractions
reliant on anaerobic energy pathways. The muscle-specific CK-M enzyme catalyzes the
reversible transfer of energy-rich phosphate from CrP to ADP and is essential for energy
provision during contractile activity, with higher CK-M activity in fast-twitch compared
to slow-twitch fibers [4,5]. Consequently, the CKM gene has emerged as a candidate that
might affect the development of aerobic and/or anaerobic phenotypes. Furthermore, ac-
cording to the GTEx portal, the G allele of the rs8111989 polymorphism is associated with
decreased expression of the MARK4 gene in skeletal muscle, which acts as a negative
regulator of the mTORC1 complex (a key factor in maintaining skeletal muscle mass) [19].
Therefore, we hypothesized that a genetic predisposition for high CK-M protein activity
may be advantageous to athletes in sports that are reliant on the contractile capacity of
fast-twitch muscle fibers, and specifically that variants associated with increased CK-M
and mTORC1 activity would be more common in strength competitors. The A-to-G substi-
tution of the rs8111989 SNP does not change the CK-M amino acid sequence but reportedly
alters CKM mRNA stability [12] and potentially CK-M expression. Further studies are
required to determine whether this mechanism influences CKM expression and skeletal
muscle phenotypes.
Our findings are not supported by a recent meta-analysis of CKM rs8111989 genotypes
and/or allele distribution in athletes and non-athletes, where the frequencies of the G
allele and GG genotype were higher in power athletes than in non-athletes [8]. The
rs8111989 SNP may also contribute to baseline aerobic capacity and differences in the
response of maximal oxygen uptake to endurance training [10,11,20,21]. Fedotovskaya and
colleagues reported that the AA genotype is associated with high values of maximal oxygen
uptake [14], whereas the G allele has been associated with combat athlete status in Polish
and Russian populations [22]. Although also reliant on fast-twitch muscle fibers, sprint- and
speed/strength-oriented sports involve a greater aerobic contribution than weightlifting
and powerlifting, potentially explaining why the GG genotype was not overrepresented
in these cohorts. Athletes with the rs8111989 AA genotype are also six times more likely
to suffer exertional muscle breakdown than AG or GG genotypes [11,23], leading to the
suggestion that the G allele protects against exertional muscle damage [13,24]. Since fast-
twitch fibers are more susceptible to exertional muscle damage [24], genetic resistance
to exertional muscle damage would be advantageous to strength-oriented athletes who
perform repetitive maximal contractions. However, the findings of the present study do
not indicate that the rs8111989 G allele carriers are predisposed to excel in strength and
power sports.
A growing body of evidence supports an association of the rs8111989 AA and GG
genotypes with endurance and strength phenotypes, respectively [12,17,21,22,25–28]. How-
ever, a tendency for G allele carriers to achieve higher maximum oxygen uptake values
has been reported [27], and several studies (together with the present study) have failed to
detect any association with athlete status or performance [8–10,13,23]. This demonstrates
that further investigation surrounding CKM variants and athletic performance phenotypes
is required. To date, 62 genetic markers have been associated with strength-power ath-
lete status [3], but only some were reported in strength sports groups (weightlifting and
powerlifting). These include SNPs of CNTFR, ACTN3, AGT, AR, HIF1A, PPARA, PPARG,
PPARGC1A, and other genes [3,9,17,29–36]. Recently, Grishina and colleagues confirmed
the association of three SNPs (rs12055409, rs4626333, and rs2273555) with strength mea-
sures in weightlifters, which were supported by functional evidence [31,32], whereas the
most comprehensive study of elite strength athletes (weightlifters and powerlifters) to date
documented 28 SNPs associated with athlete status [33]. Of those 28 SNPs, the LRPPRC
rs10186876, MMS22L rs9320823, and PHACTR1 rs6905419 polymorphisms were also asso-
ciated with competitive weightlifting performance. Importantly, that study was the first
to demonstrate the likelihood that achieving elite status in strength sports depends on a
high number of SNPs [33]. Therefore, further studies are needed to replicate those findings
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and to confirm whether those SNPs are associated with performance in strength-oriented
sports. This study does not confirm the previous associations of the CKM rs8111989 GG
genotype with power athlete status [22]. Additional studies of elite power athletes from
different nationalities are required to further substantiate our findings.
We acknowledge the limitations of the present study. Firstly, we did not include
endurance athletes and are unable to ascertain whether the rs8111989 A and G alleles are
associated with contrasting performance phenotypes. Second, participant nationalities
were restricted to Russia and Lithuania, meaning that the associations described in the
present study cannot be generalized to athletes from other countries or geographical ances-
tries. We also did not collect direct measures of athletes’ strength and power. However, our
inclusion criteria stipulated that all athletes had competed at the national or international
level, which would not be possible without the physiological characteristics associated with
elite strength phenotypes. Lastly, we studied a singular SNP and recognize that genetic
association studies represent only the first steps toward understanding the genetic factors
influencing performance traits. However, candidate gene association studies are crucial to
the direction of new analyses, such as those incorporating modern DNA technologies and
bioinformatics, to further analyze the heritability of physical capacity and to work toward
the application of genomic research into practice.
5. Conclusions
The present study reports the non-association of the CKM rs8111989 polymorphism
with elite status in athletes from sports in which anaerobic energy pathways determine
success. Therefore, the CKM rs8111989 polymorphism may not be considered as a candidate
gene to influence the performance of power athletes from Russia and Lithuania.
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